Single Dose Manufacturing Site (Pfizer vs. BIP) And Device (Prefilled Syringe vs. Prefilled Pen) Comparability Study For Bococizumab In Healthy Volunteers

NCT02458209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: bococizumab PFS:Pfizer
BIOLOGICAL: bococizumab PFS: BIP
BIOLOGICAL: bococizumab PFP

Sponsor

Pfizer